Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL)

NYSEARCA: PILL · Real-Time Price · USD
8.33
+0.02 (0.24%)
Dec 11, 2024, 4:00 PM EST - Market closed
0.24%
Assets $13.23M
Expense Ratio 1.01%
PE Ratio 15.26
Shares Out 1.60M
Dividend (ttm) $0.12
Dividend Yield 1.39%
Ex-Dividend Date Sep 24, 2024
Payout Ratio 21.19%
1-Year Return +38.37%
Volume 71,472
Open 8.27
Previous Close 8.31
Day's Range 8.06 - 8.39
52-Week Low 5.76
52-Week High 10.62
Beta 2.20
Holdings 50
Inception Date Nov 15, 2017

About PILL

Fund Home Page

The Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL) is an exchange-traded fund that is based on the S&P Pharmaceuticals Select Industry index. The fund provides 3x daily exposure to a modified equal-weighted index of pharmaceutical companies in the US. PILL was launched on Nov 15, 2017 and is issued by Direxion.

Asset Class Equity
Category Trading--Leveraged Equity
Region North America
Stock Exchange NYSEARCA
Ticker Symbol PILL
ETF Provider Direxion
Index Tracked S&P Pharmaceuticals Select Industry

Top 10 Holdings

268.57% of assets
Name Symbol Weight
S&P PHARMACEUTICALS SELECT INDEX SWAP n/a 100.85%
S&P PHARMACEUTICALS SELECT INDEX SWAP n/a 76.01%
S&P PHARMACEUTICALS SELECT INDEX SWAP n/a 49.17%
DREYFUS GOVT CASH MAN INS n/a 15.22%
GOLDMAN FINL SQ TRSRY INST 506 n/a 7.47%
GOLDMAN SACHS FIN GOV 465 INSTITUT n/a 6.36%
Corcept Therapeutics Incorporated CORT 4.22%
Bristol-Myers Squibb Company BMY 3.24%
Jazz Pharmaceuticals plc JAZZ 3.02%
Intra-Cellular Therapies, Inc. ITCI 3.02%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Sep 24, 2024 $0.029 Oct 1, 2024
Jun 25, 2024 $0.022 Jul 2, 2024
Mar 19, 2024 $0.027 Mar 26, 2024
Dec 21, 2023 $0.038 Dec 29, 2023
Sep 19, 2023 $0.035 Sep 26, 2023
Jun 21, 2023 $0.049 Jun 28, 2023
Full Dividend History

News

Can Health Care Stocks Outperform Again In 2023?

How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

2 years ago - Seeking Alpha

Pharma In Transition: Context And Opportunities

The pending separation of consumer care businesses by pharmaceutical companies is understandable and may offer investment opportunities.

Other symbols: FTXHGSKJNJPJPPPHSNYXPH
2 years ago - Seeking Alpha

Biotech Innovations Remain At Forefront

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r...

3 years ago - Seeking Alpha

3 Pharmaceutical ETFs That Could Be Due For A Rebound

These three pharmaceutical ETFs have dropped to support, which means they may be about to rebound. Support is a large concentration of buyers who have gathered around the same price level.

Other symbols: XPH
3 years ago - Benzinga

Moving Beyond COVID In Biopharma

Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12,...

3 years ago - Seeking Alpha

Healthcare: A Wide Choice Of Large And Well-Established Companies

The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets...

4 years ago - Seeking Alpha

3 Leveraged Healthcare ETFs Soaring This Month

The new coronavirus from China has claimed more than 800 lives and there are now more than 37,000 documented cases of the respiratory illness worldwide, making it more deadly than the 2003 SARS epidem...

Other symbols: CURELABU
5 years ago - Benzinga

The Trouble With Pharma

The Trouble With Pharma

5 years ago - Seeking Alpha

With Earnings On Tap, A Stir In This Leveraged Pharmaceuticals ETF

With pharmaceuticals stocks under intense political scrutiny this year, the Dynamic Pharmaceutical Intellidex Index (DZRTR) is lower by nearly 8% and is on pace for one of its worst annual performance...

5 years ago - Benzinga